NDC 42291-301-30 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-301
- Requested NDC
- 42291-301-30
- Package NDCs from labels
- 42291-301-50, 42291-301-30
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-301-10 | EA - Each | 42291-301 | 2148c67a-da4a-4fc6-9965-d2dc7283324f | 1 | 2013-02-13 |
| 42291-301-18 | EA - Each | 42291-301 | a94c3a5a-b7d2-4162-bcc7-69c42cf25512 | 1 | 2013-02-13 |
| 42291-301-27 | EA - Each | 42291-301 | a3157c8a-e4c6-4912-b9da-4665436ad940 | 1 | 2013-02-13 |
| 42291-301-30 | EA - Each | 42291-301 | 4b3388ae-99e2-4ac5-a747-7f90798c60a8 | 1 | 2013-02-13 |
| 42291-301-50 | EA - Each | 42291-301 | 5f4b3f45-a21d-4e20-a2e3-3296ff0a4325 | 1 | 2018-10-11 |
| 42291-301-90 | EA - Each | 42291-301 | 7169cf0d-6ae5-416d-81f2-8160bb398680 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4cb26d6e-7963-4fe5-903e-ab5180545066 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 100ff86c-56a8-4770-9db3-b9bc6b1bd2f7 | 2026-04-30 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | d22ed424-f365-44ca-8ef9-a08255a90ae8 | 2026-04-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | e3429322-c442-4146-bb68-bcc3a8d01552 | 2026-04-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 2625c0ef-5295-41de-9e81-88001a6cbecc | 2026-04-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 6ecf5114-2ddc-4025-a36d-1884702dc22a | 2026-04-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | f396ec70-826d-45c6-a27c-343c2fac878c | 2026-04-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 41dcc917-68d1-49f0-8223-44c21ca259ef | 2026-04-29 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 5073abda-321f-29d1-e063-6394a90a59ac | 2026-04-27 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | BluePoint Laboratories | 3368bf70-d466-4765-b2b7-7fe967a8c2b7 | 2026-04-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 500ee820-0378-6fc9-e063-6394a90a109c | 2026-04-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | dd0e12c2-1986-4ca3-a809-d703a7542419 | 2026-04-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PHOENIX RX LLC | 4f95c01f-200e-bfd7-e063-6394a90abc38 | 2026-04-16 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ce0f0d7f-da6d-47da-a4ed-fb8f72902412 | 2026-04-13 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | abb56036-88df-4720-ba78-529971671545 | 2026-04-13 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a75c9157-a1fc-44cc-89f8-c5a3742fb9ed | 2026-04-13 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d1aa4690-57b5-4a3e-ac12-85f777dbd05e | 2026-04-13 | Warnings, Adverse reactions | 6CW7F3G59X |
| RELGAABI | GABAPENTIN | Method Pharmaceuticals, LLC | 4cc6615b-5447-9c0e-e063-6394a90a2883 | 2026-04-08 | Warnings, Adverse reactions | 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 632cb507-5675-2392-0460-b09c0dd14650 | 2026-04-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | 798575b9-ddfa-4915-9574-626abbaf025f | 2026-04-04 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.